On the heels of Wednesday’s article on the closer examination of doctors’ relationships with pharmaceutical companies, an editorial in today’s New York Times calls for some house cleaning on a much higher level, in the FDA.
Earlier this week, Gardiner Harris and Janet Roberts reported in “Doctors’ Ties to Drug Makers Are Put on Close View,”
In dozens of interviews, most doctors said that these payments [from pharmaceutical companies] had no effect on their care of patients.
…
There is nothing illegal about doctors’ accepting money for marketing talks, and professional organizations have largely ignored the issue.
But research shows that doctors who have close …read more